Acer Medical Inc. (6857.TWO)
Taipei Exchange · TWD · Healthcare · Health Information Services
NT$90.50 (+0.00%) as of
Key statistics
- Market cap
- 1.42B
- EPS (TTM)
- -1.56
- Dividend yield
- 0.00%
- 52-week range
- 89.00 – 128.00
- Beta
- 0.69
- Revenue (TTM)
- 70.47M
- Profit margin
- -33.62%
- Volume
- 113.00
About Acer Medical Inc.
Acer Medical Inc. offers artificial intelligence, clinical data, and software for healthcare sector. The company offers VeriSee DR, an AI-assisted diagnostic software for diabetic retinopathy identification; VeriSee AMD, an AI-assisted screening software for age-related macular degeneration identification; VeriSee GLC, an AI-assisted screening software for glaucoma suspect; and VeriOsteo OP, an AI-assisted screening software for bone mineral density abnormalities. It also provides aiMed, a generative AI platform for healthcare environments; aiGait, balance and gait assessment software; non-mydriatic automated portable fundus camera; and portable X-ray system solutions. Acer Medical Inc. was founded in 2018 and is based in New Taipei City, Taiwan.
- Sector
- Healthcare
- Industry
- Health Information Services
- Headquarters
- New Taipei City, Taiwan
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.